+1 (404) 988-4132
Book a Demo
For Licensed Providers & Medspas
Elite Cell Source by Newera: a 503A-compounded peptide and biologics line backed by physician-guided protocols and full medical oversight.
Licensed providers onlyCredential-verifiedResearch-informed
The Standard We Hold
NPI and state licensure verified before any catalog or pricing access.
No open carts, no instant checkout. Every order comes from a verified provider.
Well-established findings clearly distinguished from emerging research.
Routed exclusively to vetted, state-licensed partners. No gray market.
Flexible Business Models
Maximum margin control, or a completely hands-off program where we carry the medical infrastructure.
Wholesale Model
Buy directly at a flat wholesale rate and set your own retail pricing.
Telehealth Model
We handle compliance, prescribing, and shipping. You refer the patient and collect a monthly revenue share.
Next-Generation Biologics
A suite designed to integrate seamlessly into your med spa's existing treatment menu.
25B · 50B · 100B vials
Perinatal tissue-derived extracellular vesicles and soluble paracrine factors, collected within hours of delivery for peak vitality and potency.
Best for Topical application after microneedling, laser resurfacing, or RF treatments.
50B · 100B · 200B EVs
A gelatinous scaffold combining a collagen and hyaluronic acid-rich matrix with a dense extracellular vesicle payload.
Best for Deep tissue support, structural scaffolding, and volume-focused applications.
100B · 200B · 400B EVs
An autologous EV concentrate from the patient's own blood, processed in an FDA-registered cGMP facility.
Best for Autologous-preference patients, hair restoration, personalized regenerative work.
Premium Compounded Peptides
503A-compounded solutions, organized around the goals your patients actually name.
01 · Weight Loss
GLP-1 era demand, dispensed only through licensed, verified channels.
GLP-1 agonist · 2.5 mg/mL
A GLP-1 receptor agonist widely used for appetite reduction and weight management.
GIP / GLP-1 · 5 mg/mL
Dual-action GIP and GLP-1 agonist for accelerated weight loss and metabolic control.
Triple-G agonist · 4 mg/mL
Targets GLP-1, GIP, and glucagon receptors. Investigational and still under clinical study.
02 · Recovery
The compounds athletic and post-procedure patients ask for by name.
Peptide · 5 mg / vial
The Body Protection Compound, studied for tissue repair, inflammation, and gut health.
Peptide · 5 mg / vial
A Thymosin Beta-4 fragment studied for cell migration, inflammation, and healing.
03 · Anti-Aging
GH-axis support that pairs naturally with the aesthetic work you already do.
Combination · 5 / 5 mg
CJC-1295 extends the GH pulse while Ipamorelin amplifies the release.
GHRH analogue · 15 mg
A GHRH analogue that stimulates the body's own GH production for recomposition.
04 · Longevity & Wellness
The protocols patients stay on, month after month.
Coenzyme · 500 mg / vial
Central to cellular energy and DNA repair, important to mitochondrial health.
Melanocortin · 10 mg
A melanocortin receptor agonist studied for desire and arousal in men and women.
The FDA-approved product (Vyleesi) uses this molecule; compounded preparations are not the same product.
Availability of specific compounds varies by provider eligibility, clinical appropriateness, and applicable state and federal regulations. Descriptions are educational summaries for licensed providers and are not treatment claims. Well-established findings are clearly distinguished from emerging areas of investigation.
Beyond Ordering
Transparent provider pricing across a verified, quality-first line.
Physician-reviewed protocols and curated literature.
Secure video meetings and scheduling with our team.
Your practice on our verified-network map, visible to patients.
From Application to Revenue
No hidden steps. No surprise fees. No confusion about what arrives, when it arrives, or what your practice does with it. Here is exactly how the program works, including the parts other suppliers do not talk about.
The Process · Realistic Expectations
What you do, what we do, and when it turns into revenue. Most suppliers stop at "application received" and skip the part where you are three weeks in wondering what happens next.
Submit your NPI, state license, and clinic details through the secure application. Free for licensed providers, about five minutes. Book an intro call first if you would rather talk it through.
Intro call optional
Our team reviews every application before any catalog, pricing, or ordering access is granted. There is no instant checkout, ever, and we decline applications that do not check out.
You will hear from a named contact, not an autoresponder
Provider pricing across the catalog, the physician-reviewed clinical library, in-platform consult scheduling, and your practice on the verified-network map.
Wholesale if you want margin control and already have prescribing staff. Telehealth if you want us to carry the medical infrastructure and you collect a recurring share. You can start with one and move later.
Wholesale orders route directly to licensed 503A fulfillment partners once payment completes. On telehealth, our medical team prescribes and medication ships to your patient's door.
Your contact stays reachable for protocol questions, patient selection, reorders, and adding compounds as your program grows.
Timelines reflect a complete application with verifiable credentials. Verification is a real review, not a formality.
When It Arrives
Compounded, labeled, and documented by a licensed 503A pharmacy. No repackaging, no unlabeled vials, no mystery about where it came from.
i.Your ordered compound, prepared by a state-licensed 503A pharmacy to the prescribed formulation and concentration.
ii.Compound, concentration, lot, and beyond-use date on the label, with the fulfilling pharmacy named. Nothing arrives anonymous.
iii.Packed to the storage requirements of the specific preparation, so it arrives usable rather than merely delivered.
iv.Refrigeration, light protection, and beyond-use dating in writing, so your staff is not guessing at the back counter.
v.The physician-reviewed protocol material for the compounds you carry, from the clinical library your access unlocks.
vi.Your contact and the reorder route, so restocking is a message rather than a fresh procurement project.
Exact packaging, label format, and vial presentation vary by which 503A partner fulfills a given order. Images are representative of pharmaceutical-grade preparations and are not photographs of a specific shipment.
First Time Adding Peptides?
Most practices overestimate how much operational change this takes. If you already run consults and dispense in-clinic, the workflow below will feel familiar.
Usually someone already in your chair. The aesthetic patient asking about weight, the post-procedure patient asking about recovery, the longevity patient already buying supplements.
Pull the physician-reviewed protocol from your clinical library. Confirm appropriateness, contraindications, and that the compound is available in your state.
Wholesale: your prescriber writes and you dispense from stock. Telehealth: you refer the patient in and our medical team takes prescribing from there.
Patient-specific or restock, through your verified account. The order routes to a licensed 503A partner once payment completes.
Check in at the interval the protocol specifies. This is where the program compounds: peptide patients return on a cycle, which is the whole reason it pairs well with device treatments.
The honest answer to the obvious question
"How much work is this really?" For a practice already running consults, the operational lift is mostly paperwork on the front end: credentialing, and deciding which model you want. The clinical part is a protocol your prescriber signs off on. The hard part is patient selection, not logistics.
Newera Aesthetics, on what practices actually ask us
Real People, Real Roles
Supplier programs get a reputation for being faceless. This one is not. Your contact has a name, the oversight is a licensed physician, and the pharmacy is one you can look up.
Your Contact · Newera
A real human who walks you through pricing, models, and onboarding, and stays with your practice after the first order. Call +1 (404) 988-4132 and you reach us, not a queue.
Medical Director · Oversight
A dedicated Medical Director develops the evidence-informed protocols behind Elite Cell Source and, on the telehealth model, handles prescribing and clinical review for referred patients.
Pharmacy · Licensed 503A
Paid orders route exclusively to vetted, state-licensed 503A compounding partners. No anonymous suppliers, no resale, no gray market, and a pharmacy license you can verify publicly.
Set Expectations
Knowing what we will not do is part of knowing who you are working with.
Ready to Start?
Pick whichever fits how you like to make decisions. All three end in the same place: a verified account and provider pricing.
Path 01
For practices ready to move.
Submit credentials and start verification today. Best if you already know you want the program and want pricing in front of you.
Apply for provider accessPath 02
For practices with questions.
Thirty minutes with a real person to walk the models, the margins, and whether this fits your patient base. No pressure, no obligation.
See available timesPath 03
For practices doing homework.
Read the catalog, the two business models, and what the program includes. Come back when the timing is right.
Browse the catalogImportant, please read. This is a business-to-business program for licensed healthcare providers and approved clinics only. Newera does not market to, sell to, or ship to patients, and verification is required before any ordering access is granted.
Product descriptions on this page are educational summaries for licensed providers. They are not treatment claims, not medical advice, and not a representation that any product is FDA-approved to diagnose, treat, cure, or prevent any disease. Compounded preparations are not FDA-approved products. Some compounds referenced here are investigational or are subject to evolving FDA guidance on compounding, and availability may change accordingly.
Biologics notice. Products described as exosomes, extracellular vesicles, or perinatal-tissue-derived preparations are biological products. They are not FDA-approved biologics, and no representation is made that any such product is licensed under Section 351 of the Public Health Service Act. Regulatory classification (including 361 vs. 351 status and any investigational-new-drug requirements for non-homologous use) is the responsibility of the ordering provider and the fulfillment partner. Availability is subject to current FDA guidance on cell, tissue, and exosome products, which continues to evolve.
Providers are responsible for patient selection, informed consent, prescribing within their license and state scope, and compliance with all applicable state and federal law. Products and protocols are made available only to eligible providers. If you are a patient, please talk to your provider.
